This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
R

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases

By 2024 ESMO Annual Meeting Insights Hub FEATURING Robbe Van den Begin
By 2024 ESMO Annual Meeting Insights Hub FEATURING Robbe Van den Begin
118 views
September 26, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

2024 ESMO Annual Meeting Insights Hub: Lung Videos

08:49
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

Feat. K. Natsuhara
07:10
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: LBA51 DUART Trial - ctDNA Dynamics and Treatment…

Feat. A. Filippi
05:10
ecancer

ESMO 2024 Insights: PIONeeR Trial - IO Resistance Pathways Investiga…

Feat. P. Tomasini
View All

Related Content

AUTOPLAY
Fred Hutchinson Cancer Center

Breast Oncology, Best of 2024

Wed, Oct 30, 2024
25:08
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

Feat. S. Tolaney, H. Rugo
12:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

Feat. P. Tarantino
11:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino
07:23
Total Health

Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted…

Feat. R. O'Regan
12:35
Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+…

Feat. S. Tolaney, H. Rugo
10:53
Kirollos Hanna

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
13:04
Douglas Beall

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

17:12
UNC Lineberger Comprehensive Cancer Center

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

Feat. A. Faso, B. Patel, K. Chen
28:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
36:18
Insights from ESMO Breast 2024 Annual Meeting

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Feat. H. Rugo
27:01
Scripps Health

CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC

Feat. S. Sammons
33:44
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive &a…

Feat. S. Tolaney, H. Rugo
27:04
Fengting Yan

Cancer Screening Molecular Tools

22:34
Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney
10:34
Sara Tolaney

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
16:19
Wassim Mchayleh

Optimizing Adjuvant Treatment in High-Risk HR+/HER2- eBC: Patient Se…

14:52
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

Feat. P. Tarantino
12:07
Sara Tolaney

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
21:31
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Summary: "Community Oncologists Highlights&quo…

Feat. S. Tolaney, H. Rugo